Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Poschner, T; Werner, P; Kocher, A; Laufer, G; Musumeci, F; Andreas, M; Russo, M.
The JenaValve pericardial transcatheter aortic valve replacement system to treat aortic valve disease
FUTUR CARDIOL. 2021; 18(2):
Doi: 10.2217/fca-2021-0065
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Andreas Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Transcatheter aortic valve replacement is a valuable alternative technique to surgery and the spectrum of therapy continues to evolve. The JenaValve Pericaridal transcatheter aortic valve replacement System allows prosthesis fixation in a native, noncalcified aortic annulus with a unique paper clip-like anchorage mechanism. The low rate of paravalvular leakage and permanent pacemaker implantation emphasizes the further widespread use of the JenaValve - despite the limited data available. In May 2021, a CE mark for the transfemoral implantation in both aortic regurgitation and aortic stenosis was granted. However, no data have been published so far. The ongoing ALIGN trials are expected to provide the pending long-term data.
- Find related publications in this database (Keywords)
- aortic regurgitation
- aortic stenosis
- cardiac surgery
- interventional cardiology
- leaflet thrombosis
- pacemaker
- paravalvular leakage
- TAVR
- valve-in-valve